Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention

Giancarlo Marenzi1, Monica De Metrio, Mara Rubino

  • 1Department of Cardiovascular Sciences, Centro Cardiologico Monzino, I.R.C.C.S, University of Milan, Milan, Italy. giancarlo.marenzi@ccfm.it

American Heart Journal
|December 15, 2010
PubMed

Insights

Acute hyperglycemia in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) significantly increases the risk of contrast-induced nephropathy (CIN) and in-hospital mortality.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Acute hyperglycemia and contrast-induced nephropathy (CIN) are common in ST-elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).
  • Both conditions are linked to higher mortality rates.
  • This study explores the relationship between acute hyperglycemia and CIN in this patient population.

Purpose of the Study:

  • To investigate the association between acute hyperglycemia and the development of contrast-induced nephropathy (CIN).
  • To assess the impact of acute hyperglycemia and CIN on in-hospital mortality in STEMI patients undergoing primary PCI.

Main Methods:

  • Prospective enrollment of 780 STEMI patients undergoing primary PCI.
  • Plasma glucose levels measured on admission; acute hyperglycemia defined as >198 mg/dL.
  • CIN defined as a serum creatinine increase >25% within 72 hours.

Main Results:

  • 19% of patients had acute hyperglycemia, and 14.5% developed CIN.
  • Acute hyperglycemia was associated with a 2-fold higher incidence of CIN (27% vs 12%).
  • Patients with acute hyperglycemia and those with CIN had significantly higher in-hospital mortality rates (12% vs 3% and 27% vs 0.9%, respectively).
  • Acute hyperglycemia independently predicted both CIN and in-hospital mortality.

Conclusions:

  • Acute hyperglycemia is a significant risk factor for CIN in STEMI patients undergoing primary PCI.
  • Acute hyperglycemia is associated with increased in-hospital mortality in this patient group.
  • The combination of acute hyperglycemia and CIN presents the highest mortality risk.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...